Medical News

RSS

Titan completes 60% enrollment in confirmatory Phase 3 clinical study of Probuphine for opioid addiction

Titan Pharmaceuticals, Inc. today announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid addiction, and the study is expected to complete enrollment by early fourth quarter of this year, which is almost three months ahead of schedule.

3 Aug 2010

Dental school students receive grants for showing outstanding leadership abilities

Sixty-one outstanding dental school students received nearly a quarter of a million dollars in grants this year from Delta Dental of California, Delta Dental of Pennsylvania and affiliated companies, officials announced today.

3 Aug 2010

West Pharmaceutical Services second-quarter gross profit increases 5.8% to $83.2 million

West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.

3 Aug 2010

Caliper Life Sciences second-quarter GAAP revenue decreases 10% to $29.0 million

Caliper Life Sciences, Inc., today reported results for its second quarter ended June 30, 2010. Second quarter GAAP revenue decreased 10% to $29.0 million from $32.1 million in the same period in 2009 as a result of divestitures in 2010 and 2009. Revenue from on-going business increased 4% on a reported basis and 6% on an organic basis (which assumes constant currency).

3 Aug 2010

First Edition: August 3, 2010

Today's headlines include reports about a federal judge's ruling regarding the Virginia challenge to the health reform law and about the Senate's latest delay in consideration of a state aid package that includes Medicaid assistance.

3 Aug 2010

Entomology 2010 to take place December 12-15 in San Diego, California

This year's ESA Annual Meeting will take place December 12-15, 2010 in San Diego, California, where 3,000 scientists are expected to gather from around the world to exchange scientific information and ideas, enhance professional knowledge and skills, network with colleagues and re-acquaint with old friends, and conduct the business of the Society.

3 Aug 2010

Investigators explore legal, ethical permissibility of carrying out request specific to VAD

Patients have the right to refuse or request the withdrawal of any unwanted treatment. In an article published in the online issue of Mayo Clinic Proceedings, investigators explore the legal and ethical permissibility of carrying out such a request specific to a ventricular assist device.

3 Aug 2010

OCM announces findings from Diagnostic Management Program

One Call Medical, the nation's leading provider of diagnostic testing (including MRI and CT scans) and specialty services (e.g. transportation and translation), today announced findings from its Diagnostic Management Program, revealing that on average, a typical workers' compensation payer may have as much as two-thirds of its diagnostic radiology referrals go "unmanaged," leading to overpayments, inefficiencies, and quality issues in the diagnostic referral, scheduling, and results process.

3 Aug 2010

AHF praises NJ for saving drug program, criticizes BMS for refusal to cut prices for ADAPs

AIDS Healthcare Foundation (AHF) lauded innovative New Jersey state health officials who were able to keep providing nearly 1,000 AIDS patients throughout the state with access to lifesaving antiretroviral medications with an 11th hour fix to a struggling state AIDS drug distribution program that was set to cut them from the program's eligibility rolls as of Sunday, August 1st.

3 Aug 2010

EITC programs directly linked to higher birth weights: Study

Relieving poverty during pregnancy can reduce the incidence of low- birth-weight babies and may help break the succession of childhood poor health, a study published in the August 2010 issue of the American Sociological Review has found.

3 Aug 2010

CorVel quarterly revenues increase 13% to $91.5 million

CorVel Corporation reported earnings per share of $0.64 for the quarter ended June 30, 2010, a 30% increase compared to $0.49 in the same quarter of the prior fiscal year. The Company reported quarterly revenues of $91.5 million, a 13% increase compared to $81.3 million in the same quarter of the prior fiscal year.

3 Aug 2010

Vical second-quarter revenues decrease to $2.1 million

Vical Incorporated today reported financial results for the three months and six months ended June 30, 2010. Revenues decreased to $2.1 million for the second quarter of 2010 from $4.0 million for the second quarter of 2009, primarily as a result of a $1.5 million milestone payment in 2009 from Merck & Co., Inc., based on Merck's ongoing Phase 1 clinical-stage development of an investigational cancer vaccine.

3 Aug 2010

Health and Safety Watch launches new website to help Canadians access health-related information

Health and Safety Watch Inc., an organization established to help Canadians manage all types of health and safety hazards, today officially launched www.HealthandSafetyWatch.com, a new website designed to give Canadians easy access to real-time information about the 500-plus product, food, and drug recalls, as well as health advisories, that occur every year.

3 Aug 2010

Emerson Ecologics to exclusively distribute Sedona Labs Pro probiotic products

Emerson Ecologics, LLC, the leading provider of professional-grade nutritional supplements to the healthcare practitioner market, announces a new strategic partnership with Nutri-Health as the exclusive distributor for their practitioner brand, Sedona Labs Pro™. Effective immediately, all customer service, marketing and order fulfillment for the complete line of Sedona Labs Pro products will be handled by Emerson Ecologics.

3 Aug 2010

DUSA Pharmaceuticals total product revenues for second-quarter 2010 increase 25% to $8.7 million

DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan Photodynamic Therapy and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the second quarter ended June 30, 2010.

3 Aug 2010

MEDNAX second-quarter revenue increases 9% to $349.1 million

MEDNAX, Inc. today reported earnings per share of $1.04 for the three months ended June 30, 2010, that were driven by contributions resulting from the Company's acquisitions and ongoing operating efficiencies.

3 Aug 2010

Acorda second-quarter net loss decreases to $6.8 million

Acorda Therapeutics, Inc. today announced its financial results for the second quarter of 2010.

3 Aug 2010

Effects of natural compound against prostate cancer published in Integrative Cancer Therapies

Researchers at Columbia University have published the dramatic effects of a natural 33-ingredient compound against prostate cancer cell lines. The impressive results are found in the most recent publication of Integrative Cancer Therapies.

3 Aug 2010

Insulin resistance from obesity leads to lower cognitive performance in children: Research

A study by researchers at NYU Langone Medical Center have found that obese adolescents with type 2 diabetes have diminished cognitive performance and subtle abnormalities in the brain as detected by Magnetic Resonance Imaging (MRI). Identification of cognitive impairments as a complication of type 2 diabetes emphasizes the importance of addressing issues of inactivity and obesity, two important risk factors for the development of the disease among the young.

3 Aug 2010

First patient treated in Phase Ib expansion study of CUDC-101

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase Ib expansion study for CUDC-101 in patients with advanced head and neck, gastric, breast and liver cancers.

3 Aug 2010

Medical News

Titan completes 60% enrollment in confirmatory Phase 3 clinical study of Probuphine for opioid addiction

Dental school students receive grants for showing outstanding leadership abilities

West Pharmaceutical Services second-quarter gross profit increases 5.8% to $83.2 million

Caliper Life Sciences second-quarter GAAP revenue decreases 10% to $29.0 million

First Edition: August 3, 2010

Entomology 2010 to take place December 12-15 in San Diego, California

Investigators explore legal, ethical permissibility of carrying out request specific to VAD

OCM announces findings from Diagnostic Management Program

AHF praises NJ for saving drug program, criticizes BMS for refusal to cut prices for ADAPs

EITC programs directly linked to higher birth weights: Study

CorVel quarterly revenues increase 13% to $91.5 million

Vical second-quarter revenues decrease to $2.1 million

Health and Safety Watch launches new website to help Canadians access health-related information

Emerson Ecologics to exclusively distribute Sedona Labs Pro probiotic products

DUSA Pharmaceuticals total product revenues for second-quarter 2010 increase 25% to $8.7 million

MEDNAX second-quarter revenue increases 9% to $349.1 million

Acorda second-quarter net loss decreases to $6.8 million

Effects of natural compound against prostate cancer published in Integrative Cancer Therapies

Insulin resistance from obesity leads to lower cognitive performance in children: Research

First patient treated in Phase Ib expansion study of CUDC-101

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Latest News